Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2013-11-08

PRAC recommends using acipimox only as additional or alternative treatment to lower high triglyceride levels

View source ↗

Summary

EU authorities recommend using acipimox only as an additional or alternative treatment to lower high triglyceride levels, not as a first-line or sole therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acipimox (Acipimox)